Page 53 - PACE: Advanced Prostate Cancer Consensus

ENZAMET Overall Survival: Enzalutamide Significantly

Reduced the Risk of Death by 33%

Enzalutamide
1.00 NSAA

Proportion Alive 0.75 0.72 (0.68 to 0.76) 0.80 (0.75 to 0.83)
Proportion Alive at 36 months (95% CI)

Enzalutamide
0.50
NSAA

0.25
Hazard ratio = 0.67 (95% CI: 0.52 to 0.86)
Log-rank p=0.002

0.00

0 6 12 18 24 30 36 42 48

Months
Number at risk

NSAA 562 551 531 501 452 311 174 86 32
Enzalutamide 563 558 541 527 480 340 174 106 45